BSX
Boston Scientific Corporation
- Total liabilities, 2025
- $19.2B
- YoY, 2025
- +10.4%
- 5-year CAGR
- +4.4%
- 10-year CAGR
- +5.0%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $19.2B | +10.4% |
| 2024 | $17.4B | +11.4% |
| 2023 | $15.6B | +4.8% |
| 2022 | $14.9B | −4.6% |
| 2021 | $15.6B | +1.0% |
| 2020 | $15.5B | −7.4% |
| 2019 | $16.7B | +36.0% |
| 2018 | $12.3B | +2.0% |
| 2017 | $12.0B | +5.9% |
| 2016 | $11.4B | −3.8% |
| 2015 | $11.8B | +11.8% |
| 2014 | $10.6B | +5.3% |
| 2013 | $10.0B | −2.5% |
| 2012 | $10.3B | +3.5% |
| 2011 | $9.9B | −8.3% |
| 2010 | $10.8B | −15.9% |
| 2009 | $12.9B | −7.8% |
| 2008 | $14.0B | — |